Biopharma Updates: Sumitomo Surges on US Sales While INmune Bio Pushes Cancer Pipeline
Sumitomo Pharma is feeling pretty optimistic about its recently ended fiscal year. Riding a wave of strong North American sales,...
Year: 2026
Tesla’s Next Act: Beyond Automotive Dominance and Into the “Macrohard” Era
The modern business landscape moves at a blistering pace, and keeping a pulse on industry giants requires looking well beyond...
AvePoint Braces for Earnings: Can ARR Growth Revive Investor Confidence?
Approaching Earnings With a Lot to Prove AvePoint Inc. (NASDAQ: AVPT) is stepping up to the plate this Thursday after...
Apple Crushes Earnings Estimates Amidst Historic Gold Volatility
Markets closed with a mix of optimism and trepidation on Friday as Apple delivered a stunning earnings beat for the...
